April 29, 2020 / 12:45 PM / a month ago

BRIEF-Enzo Announces Issuance Of U.S. Patent For Methods Of Using Proprietary Compound SK1-I In Patients Exploring Options For Development As A Potential Treatment For Covid-19

April 29 (Reuters) - Enzo Biochem Inc:

* ENZO ANNOUNCES ISSUANCE OF U.S. PATENT FOR METHODS OF USING PROPRIETARY COMPOUND SK1-I IN PATIENTS; EXPLORING OPTIONS FOR DEVELOPMENT AS A POTENTIAL TREATMENT FOR COVID-19

* ENZO BIOCHEM INC - EXPLORING AVENUES FOR DEVELOPMENT OF SK1-I AS A POTENTIAL TREATMENT FOR COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below